Vireo Growth (VREOF) Liabilities from Discontinued Operations (2020 - 2025)

Vireo Growth's (VREOF) quarterly Liabilities from Discontinued Operations came in at 89334872.0 in Q3 2025, up 1.02% year-on-year from 88437021.0 in Q3 2024, and little changed quarter-over-quarter from 89379390.0 in Q2 2025.

Vireo Growth (VREOF) Liabilities from Discontinued Operations (2020 - 2025) Analysis & Trends

Vireo Growth has disclosed Liabilities from Discontinued Operations across 6 years of filings, most recently posting 89334872.0 for Q3 2025.

  • Liabilities from Discontinued Operations for Q3 2025 came in at 89334872.0, up 1.02% year-over-year; the trailing twelve-month figure through Sep 2025 was 89334872.0 (up 1.02% YoY), and the FY2024 annual result was 89387203.0, up 1.2% from the prior year.
  • Liabilities from Discontinued Operations came in at 89334872.0 for Q3 2025 at Vireo Growth, roughly flat from 89379390.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 89387203.0 in Q4 2024 to a low of 116803.0 in Q3 2021.
  • The 5-year median for Liabilities from Discontinued Operations is 81925789.0 (2023), against an average of 58887381.31.
  • Across the five-year window, Liabilities from Discontinued Operations jumped 6592.16% in 2023 and advanced 1.02% in 2025, its largest moves.
  • Vireo Growth's Liabilities from Discontinued Operations stood at 116803.0 in 2021, then surged by 1029.98% to 1319847.0 in 2022, then surged by 6592.16% to 88326323.0 in 2023, then increased by 1.2% to 89387203.0 in 2024, then decreased by 0.06% to 89334872.0 in 2025.
  • The last three Liabilities from Discontinued Operations figures came in at 89334872.0 (Q3 2025), 89379390.0 (Q2 2025), and 89351157.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 89.33 Mn
Sep 30, 2025 89.33 Mn
Jun 30, 2025 89.38 Mn
Jun 30, 2025 89.38 Mn
Mar 31, 2025 89.35 Mn
Mar 31, 2025 89.35 Mn
Dec 31, 2024 89.39 Mn
Dec 31, 2024 89.39 Mn
Sep 30, 2024 88.44 Mn
Sep 30, 2024 88.44 Mn
Jun 30, 2024 88.41 Mn
Jun 30, 2024 88.41 Mn
Mar 31, 2024 88.37 Mn
Mar 31, 2024 88.37 Mn
Dec 31, 2023 88.33 Mn
Dec 31, 2023 88.33 Mn
Sep 30, 2023 75.44 Mn
Sep 30, 2023 75.44 Mn
Jun 30, 2023 75.15 Mn
Jun 30, 2023 75.15 Mn